Bitter Melon (Momordica charantia L.) supplementation has no effect on hypercholesterolemia and atherosclerosis in mice

3Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Bitter melon (BM; Momordica charantia L.) has been reported to ameliorate diet-induced obesity and dyslipidemia. However, the effects of BM on atherosclerosis have not been determined. This study investigated the effects of BM diet-induced atherosclerosis in LDL receptor–deficient mice. A total of 30 female mice (aged 6–8 wk) were fed a saturated fat–enriched diet. In group 1 (n = 10), mice were fed this diet alone, whereas mice in groups 2 and 3 (n = 10/group) were fed the diet supplemented with BM either 0.1% or 1% by weight. After 12 wk, body weight, plasma cholesterol, and atherosclerotic plaque areas were analyzed. No significant differences in body weight and plasma cholesterol concentrations were observed among the groups. Also, BM supplementation did not affect atherosclerosis development. In conclusion, dietary BM has no effect on plasma cholesterol concentration and atherogenesis in hypercholesterolemic mice.

Cite

CITATION STYLE

APA

Mohammadmoradi, S., Howatt, D. A., Lu, H. S., Daugherty, A., & Saha, S. P. (2020). Bitter Melon (Momordica charantia L.) supplementation has no effect on hypercholesterolemia and atherosclerosis in mice. Current Developments in Nutrition, 4(10). https://doi.org/10.1093/cdn/nzaa148

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free